$PLX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Protalix BioTherapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in Protalix BioTherapeutics, Inc.. Get notifications about new insider transactions in Protalix BioTherapeutics, Inc. for free.

Page:   1 2 3 4 4 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 13 2020PLXProtalix BioTherap ...Rubin EyalSr. VP and CFOGrantA0.00246,1460246,1460 to 246.1 K
Aug 13 2020PLXProtalix BioTherap ...Bashan DrorPresident and CEOGrantA0.00447,9270447,9270 to 447.9 K
Aug 13 2020PLXProtalix BioTherap ...Naos YaronSr. VP, OperationsOption ExerciseA3.59122,656440,335122,656
Jul 08 2020PLXProtalix BioTherap ...Hayon YaelVP, Research & Deve ...Option ExerciseA3.73129,771484,046129,771
Jun 08 2020PLXProtalix BioTherap ...Almon Einat BrillSVP, Chief Developm ...Option ExerciseA3.59196,995707,212196,995
Apr 13 2020PLXProtalix BioTherap ...Schwartz AharonDirectorBuyP2.4364,000155,26464,0000 to 64 K
Feb 05 2020PLXProtalix BioTherap ...Bronfeld ZeevDirectorOption ExerciseA3.70240,000888,000240,000
Jan 22 2020PLXProtalix BioTherap ...Granot DavidDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Bar-Shalev AmosDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Schwartz AharonDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Boudes Pol FDirectorOption ExerciseA3.5540,000142,00040,000
Jan 22 2020PLXProtalix BioTherap ...Melincoff Gwen ADirectorOption ExerciseA3.5540,000142,00040,000
Sep 24 2019PLXProtalix BioTherap ...Rubin EyalSr. VP & CFOOption ExerciseA0.20800,000160,000800,000
Jul 02 2019PLXProtalix BioTherap ...Bashan DrorPresident & CEOOption ExerciseA0.471,600,000750,4001,600,000
Sep 14 2018PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseA0.56700,000392,000700,000
Sep 14 2018PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...Option ExerciseA0.56700,000392,000700,000
Sep 14 2018PLXProtalix BioTherap ...Naos YaronSr. VP, OperationsOption ExerciseA0.56600,000336,000600,000
Sep 14 2018PLXProtalix BioTherap ...Manor MoshePresident & CEOOption ExerciseA0.561,300,000728,0001,300,000
Sep 14 2018PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DOption ExerciseA0.56700,000392,000700,000
May 16 2017PLXProtalix BioTherap ...Manor MoshePresident & CEOBuyP0.8150,00040,50050,0000 to 50 K
Dec 06 2016PLXProtalix BioTherap ...Camber Capital Management LLC10% OwnerSellS0.322,500,000792,00010,775,00013.3 M to 10.8 M (-18.83 %)
Sep 16 2016PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DOption ExerciseM0.00122,1621220
Sep 16 2016PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DBuyM0.00122,162122585,916463.8 K to 585.9 K (+26.34 %)
Dec 15 2015PLXProtalix BioTherap ...Maimon YossiVice President & CF ...BuyP0.7810,0007,80010,0000 to 10 K
May 07 2015PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseA1.72250,000430,000250,000
May 07 2015PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DOption ExerciseA1.72275,000473,000275,000
May 07 2015PLXProtalix BioTherap ...Palash TzviChief Operating Off ...Option ExerciseA1.72125,000215,000125,000
May 07 2015PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...Option ExerciseA1.72250,000430,000250,000
Oct 06 2014PLXProtalix BioTherap ...Bronfeld ZeevDirectorBuyJ0.00324,37202,162,4811.8 M to 2.2 M (+17.65 %)
Oct 06 2014PLXProtalix BioTherap ...Bronfeld ZeevDirectorSellJ0.001,509,948001.5 M to 0 (-100.00 %)
Nov 03 2014PLXProtalix BioTherap ...Manor MoshePresident & CEOOption ExerciseA2.37900,0002,133,000900,000
Sep 18 2014PLXProtalix BioTherap ...Bronfeld ZeevDirectorBuyJ0.001,838,10901,838,1090 to 1.8 M
Sep 18 2014PLXProtalix BioTherap ...Bronfeld ZeevDirectorSellJ0.008,556,37101,509,94810.1 M to 1.5 M (-85.00 %)
Sep 18 2014PLXProtalix BioTherap ...Bio-Cell Ltd10% OwnerSellJ0.008,556,37101,509,94810.1 M to 1.5 M (-85.00 %)
Aug 15 2014PLXProtalix BioTherap ...Bronfeld ZeevDirectorSellS2.474,400,00010,868,00010,066,31914.5 M to 10.1 M (-30.42 %)
Aug 15 2014PLXProtalix BioTherap ...Bio-Cell Ltd10% OwnerSellS2.474,400,00010,868,00010,066,31914.5 M to 10.1 M (-30.42 %)
Jul 24 2014PLXProtalix BioTherap ...Yanai ShlomoDirectorOption ExerciseA3.37150,000505,500150,000
Aug 16 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.072,33011,8134,915,3834.9 M to 4.9 M (-0.05 %)
Aug 16 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.085,00025,4004,917,7134.9 M to 4.9 M (-0.10 %)
Aug 16 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.075,00025,3504,922,7134.9 M to 4.9 M (-0.10 %)
Aug 16 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.05100,000505,0004,927,7135 M to 4.9 M (-1.99 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.715,00028,5505,037,7115 M to 5 M (-0.10 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.7210,00057,2005,042,7135.1 M to 5 M (-0.20 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.753,00017,2505,052,7135.1 M to 5.1 M (-0.06 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.793001,7375,055,7135.1 M to 5.1 M (-0.01 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.951,89811,2935,056,0135.1 M to 5.1 M (-0.04 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.922,50014,8005,057,9115.1 M to 5.1 M (-0.05 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.912,50014,7755,060,4115.1 M to 5.1 M (-0.05 %)
Mar 12 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.8210,00058,2005,062,9115.1 M to 5.1 M (-0.20 %)
Mar 14 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.7010,00057,0005,027,7135 M to 5 M (-0.20 %)
Mar 08 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.733,43519,6835,072,9115.1 M to 5.1 M (-0.07 %)
Mar 08 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.715,00028,5505,076,3465.1 M to 5.1 M (-0.10 %)
Mar 08 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.717003,9975,081,3465.1 M to 5.1 M (-0.01 %)
Mar 08 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.692,00011,3805,082,0465.1 M to 5.1 M (-0.04 %)
Mar 08 2013PLXProtalix BioTherap ...Akirov AlfredDirectorSellS5.682,00011,3605,084,0465.1 M to 5.1 M (-0.04 %)
Jul 18 2012PLXProtalix BioTherap ...Maimon YossiVice President & CF ...GrantA0.00185,0000185,0000 to 185 K
Jul 18 2012PLXProtalix BioTherap ...Lauterbach Sandra LeighVP, Sales & Commerc ...GrantA0.0020,000020,0000 to 20 K
Jul 18 2012PLXProtalix BioTherap ...Palash TzviChief Operating Off ...GrantA0.00102,0000102,0000 to 102 K
Jul 18 2012PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DGrantA0.00210,0000210,0000 to 210 K
Jul 18 2012PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...GrantA0.00185,0000185,0000 to 185 K
Jul 18 2012PLXProtalix BioTherap ...Aviezer DavidPresident & CEOGrantA0.00418,0000418,0000 to 418 K
May 04 2012PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.13300,0002,139,000463,754763.8 K to 463.8 K (-39.28 %)
May 04 2012PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseM2.6550,000132,5000
May 04 2012PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseM0.9775,96473,8370
May 04 2012PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...SellS7.13125,964898,1230126 K to 0 (-100.00 %)
May 04 2012PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...BuyM2.6550,000132,500125,96476 K to 126 K (+65.82 %)
May 04 2012PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...BuyM0.9775,96473,83775,9640 to 76 K
May 04 2012PLXProtalix BioTherap ...Aviezer DavidPresident & CEOOption ExerciseM0.97123,733120,268853,563
May 04 2012PLXProtalix BioTherap ...Aviezer DavidPresident & CEOOption ExerciseM0.12326,26739,1520
May 04 2012PLXProtalix BioTherap ...Aviezer DavidPresident & CEOSellS7.13450,0003,208,5000450 K to 0 (-100.00 %)
May 04 2012PLXProtalix BioTherap ...Aviezer DavidPresident & CEOBuyM0.97123,733120,268450,000326.3 K to 450 K (+37.92 %)
May 04 2012PLXProtalix BioTherap ...Aviezer DavidPresident & CEOBuyM0.12326,26739,152326,2670 to 326.3 K
May 04 2012PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...Option ExerciseM2.6550,000132,5000
May 04 2012PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...Option ExerciseM0.97116,848113,5760
May 04 2012PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...SellS7.13166,8481,189,6260166.8 K to 0 (-100.00 %)
May 04 2012PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...BuyM2.6550,000132,500166,848116.8 K to 166.8 K (+42.79 %)
May 04 2012PLXProtalix BioTherap ...Almon Einat BrillSVP, Product Develo ...BuyM0.97116,848113,576116,8480 to 116.8 K
Oct 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseM0.9777,76975,59175,964
Oct 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Payment of ExerciseF9.737,76975,59207.8 K to 0 (-100.00 %)
Oct 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...BuyM0.9777,76975,5910-77,769 to 0 (-100.00 %)
Oct 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...SellS9.6770,000676,900070 K to 0 (-100.00 %)
Oct 06 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...Option ExerciseM0.9770,00068,040116,848
Oct 06 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...BuyM0.9770,00068,0400-70,000 to 0 (-100.00 %)
Oct 06 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS9.2915,000139,350015 K to 0 (-100.00 %)
Oct 06 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS9.0820,000181,600020 K to 0 (-100.00 %)
Oct 06 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS9.0235,000315,700035 K to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseM0.9770,00068,040153,733
Sep 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...BuyM0.9770,00068,0400-70,000 to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...SellS8.1631,500257,040031.5 K to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...SellS8.0038,500308,000038.5 K to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...Option ExerciseM0.9745,26043,993186,848
Sep 08 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...Option ExerciseM0.404,7401,8910
Sep 08 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...BuyM0.9745,26043,9930-45,260 to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...BuyM0.404,7401,8910-4,740 to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS8.1622,500183,600022.5 K to 0 (-100.00 %)
Sep 08 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS8.0027,500220,000027.5 K to 0 (-100.00 %)
Sep 07 2010PLXProtalix BioTherap ...Palash TzviChief Operating Off ...Option ExerciseA7.55160,0001,208,000160,000
Aug 09 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.004,61932,333763,754768.4 K to 763.8 K (-0.60 %)
Aug 09 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.0048,408338,856768,373816.8 K to 768.4 K (-5.93 %)
Jun 23 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.0052,973370,811816,781869.8 K to 816.8 K (-6.09 %)
May 03 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.0012,69188,837869,754882.4 K to 869.8 K (-1.44 %)
Apr 16 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.001,3099,163882,445883.8 K to 882.4 K (-0.15 %)
Mar 25 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.0050,000350,000883,754933.8 K to 883.8 K (-5.35 %)
Mar 25 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.08202,7001,435,116933,7541.1 M to 933.8 K (-17.84 %)
Mar 25 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS7.02127,300893,6461,136,4541.3 M to 1.1 M (-10.07 %)
Feb 26 2010PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseA6.90130,000897,000130,000
Feb 26 2010PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DOption ExerciseA6.90145,0001,000,500145,000
Feb 26 2010PLXProtalix BioTherap ...Aviezer DavidPresident & CEOOption ExerciseA6.90250,0001,725,000250,000
Feb 26 2010PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...Option ExerciseA6.90130,000897,000130,000
Feb 09 2010PLXProtalix BioTherap ...Lauterbach Sandra LeighVP, Sales & Commerc ...Option ExerciseA6.81160,0001,089,600160,000
Dec 09 2009PLXProtalix BioTherap ...Bar-Shalev AmosDirectorBuyP8.206805,5761,6801,000 to 1.7 K (+68.00 %)
Dec 09 2009PLXProtalix BioTherap ...Bar-Shalev AmosDirectorBuyP8.681,0008,6801,0000 to 1,000
Nov 13 2009PLXProtalix BioTherap ...Hurvitz EliDirectorOption ExerciseM0.003,384,5023,3850
Nov 13 2009PLXProtalix BioTherap ...Hurvitz EliDirectorSellJ0.004,443,4430455,2404.9 M to 455.2 K (-90.71 %)
Nov 13 2009PLXProtalix BioTherap ...Hurvitz EliDirectorPayment of ExerciseF11.332993,3884,898,6834.9 M to 4.9 M (-0.01 %)
Nov 13 2009PLXProtalix BioTherap ...Hurvitz EliDirectorBuyM0.003,384,5023,3854,898,9821.5 M to 4.9 M (+223.48 %)
Nov 13 2009PLXProtalix BioTherap ...Hurvitz EliDirectorSellS10.76250,0002,690,0001,514,4801.8 M to 1.5 M (-14.17 %)
Nov 13 2009PLXProtalix BioTherap ...Hurvitz EliDirectorSellS10.001,121,96711,219,6701,764,4802.9 M to 1.8 M (-38.87 %)
Oct 21 2009PLXProtalix BioTherap ...Aviezer DavidCEO and PresidentOption ExerciseM0.12247,49029,699326,267
Oct 21 2009PLXProtalix BioTherap ...Aviezer DavidCEO and PresidentPayment of ExerciseF9.133,25329,70003.3 K to 0 (-100.00 %)
Oct 21 2009PLXProtalix BioTherap ...Aviezer DavidCEO and PresidentBuyM0.12247,49029,6990-247,490 to 0 (-100.00 %)
Oct 21 2009PLXProtalix BioTherap ...Aviezer DavidCEO and PresidentSellS9.3634,238320,468034.2 K to 0 (-100.00 %)
Oct 21 2009PLXProtalix BioTherap ...Aviezer DavidCEO and PresidentSellS9.4560,000567,000060 K to 0 (-100.00 %)
Oct 21 2009PLXProtalix BioTherap ...Aviezer DavidCEO and PresidentSellS9.43150,0001,414,5000150 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...Option ExerciseM0.4093,95437,4884,740
Oct 19 2009PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...Payment of ExerciseF9.483,95437,48404 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...BuyM0.4093,95437,4880-93,954 to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS9.4338,320361,358038.3 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS9.3923,680222,355023.7 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Almon Einat BrillVP, Product Develop ...SellS9.3928,000262,920028 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS9.4343,120406,6221,263,7541.3 M to 1.3 M (-3.30 %)
Oct 19 2009PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS9.3925,680241,1351,306,8741.3 M to 1.3 M (-1.93 %)
Oct 19 2009PLXProtalix BioTherap ...Shaaltiel YosephExecutive VP, R&DSellS9.3931,200292,9681,332,5541.4 M to 1.3 M (-2.29 %)
Oct 19 2009PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Option ExerciseM0.97167,698163,002223,733
Oct 19 2009PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...Payment of ExerciseF9.2117,698162,999017.7 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...BuyM0.97167,698163,0020-167,698 to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...SellS9.3540,300376,805040.3 K to 0 (-100.00 %)
Oct 19 2009PLXProtalix BioTherap ...Maimon YossiVP, Chief Financial ...SellS9.50109,7001,042,1500109.7 K to 0 (-100.00 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.255,00036,2507,788,2417.8 M to 7.8 M (-0.06 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.203,58125,7837,793,2417.8 M to 7.8 M (-0.05 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.186,41946,0887,796,8227.8 M to 7.8 M (-0.08 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.162001,4327,803,2417.8 M to 7.8 M (0.00 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.157005,0057,803,4417.8 M to 7.8 M (-0.01 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.144,68933,4797,804,1417.8 M to 7.8 M (-0.06 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.126004,2727,808,8307.8 M to 7.8 M (-0.01 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.111,80112,8057,809,4307.8 M to 7.8 M (-0.02 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.101,3009,2307,811,2317.8 M to 7.8 M (-0.02 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.093302,3407,812,5317.8 M to 7.8 M (0.00 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS7.063802,6837,812,8617.8 M to 7.8 M (0.00 %)
Sep 03 2009PLXProtalix BioTherap ...FROST PHILLIP MD ET AL10% OwnerSellS6.892,50017,2257,813,2417.8 M to 7.8 M (-0.03 %)

Page:   1 2 3 4 4 next >